Private Advisor Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Private Advisor Group’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,076	Closed	-$277K	–	2655
2026 Q1	$277K	Sell	8,076 -3,300	-29%	-$113K	﹤0.01%	2235
2025 Q4	$375K	Buy	+11,376	New	+$354K	﹤0.01%	2008
2020 Q3	–	Sell	-640	Closed	-$15K	–	2273
2020 Q2	$15K	Buy	+640	New	+$14.2K	﹤0.01%	2720

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Private Advisor Group's FTXH Position: Q2 2026 in Review

Private Advisor Group sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2026, closing a stake of 8,076 shares — an estimated $277K sold.

Private Advisor Group first reported a position in FTXH in Q2 2020 and held it in 3 quarters. The position peaked at $375K in Q4 2025. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Private Advisor Group reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
Private Advisor Group sold 8,076 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $277K.
Private Advisor Group first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2020 and held it in 3 quarters.
Private Advisor Group's First Trust Nasdaq Pharmaceuticals ETF position peaked at $375K in Q4 2025.
30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.